PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor-Reference-Cited by-同舟云学术

PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor

Published:2021-09 Issue:9 Volume:14 Page:101152
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Koga Satoko,Onishi Hideya,Masuda Shogo,Fujimura Akiko,Ichimiya Shu,Nakayama Kazunori,Imaizumi Akira,Nishiyama Kenichi,Kojima Masayuki,Miyoshi Kei,Nakamura Katsuya,Umebayashi Masayo,Morisaki Takashi,Nakamura Masafumi

Funder

Japan Society for the Promotion of Science

Kyushu University

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference36 articles.

1. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death;Ishida;EMBO J.,1992

2. Enhancement of antitumor immunity by CTLA-4 blockade;Leach;Science,1996

3. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N. Eng. J. Med.,2015

4. PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor;Fujimura;Cancer Immunol. Immunother.,2019

5. Cytoskeletal protein tyrosine phosphatase PTPH1 reduces T cell antigen receptor signaling;Han;Eur. J. Immunol.,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating the Prognostic Biomarkers and Immune Correlations in the Co- occurrence of Chronic Obstructive Pulmonary Disease and Lung Squamous Cell Carcinoma;2024-03-20

2. Inhibition of PTPN3 Expressed in Activated Lymphocytes Enhances the Antitumor Effects of Anti-PD-1 Therapy in Head and Neck Cancer, Especially in Hypoxic Environments;Journal of Immunotherapy;2024-02-01

3. Targeting Protein Tyrosine Phosphatases to Improve Cancer Immunotherapies;Cells;2024-01-25

4. Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy;European Journal of Medical Research;2024-01-03

5. Neuroendocrine Neoplasms;PET Clinics;2023-04